ERIN MILLIGAN

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. pmc Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain
    Ellen C Dengler
    Department of Neurosciences, UNM School of Medicine, University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
    J Neuroinflammation 11:92. 2014
  2. pmc Glia in pathological pain: a role for fractalkine
    E D Milligan
    Department of Neurosciences, University of New Mexico, Health Sciences Center, Albuquerque, NM 87131 0001 USA
    J Neuroimmunol 198:113-20. 2008
  3. pmc Pathological and protective roles of glia in chronic pain
    Erin D Milligan
    Department of Neurosciences, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131 0001, USA
    Nat Rev Neurosci 10:23-36. 2009
  4. ncbi request reprint Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats
    E D Milligan
    Department of Psychology and the Center for Neuroscience, University of Colorado at Boulder, Boulder, CO 80309 0345, USA
    Eur J Neurosci 20:2294-302. 2004

Collaborators

  • L R Watkins
  • STEVEN MAIER
  • Ellen C Dengler
  • Eugene Limanovich
  • Lauren A Alberti
  • Daniel R Moezzi
  • Brandi N Bowman
  • James A Wallace
  • Jenny L Wilkerson
  • Audra A Kerwin

Detail Information

Publications4

  1. pmc Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain
    Ellen C Dengler
    Department of Neurosciences, UNM School of Medicine, University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
    J Neuroinflammation 11:92. 2014
    ..Previous reports identified phagocytic immune cells present in the peri-spinal milieu surrounding the i.t injection site that may play a role in transgene uptake resulting in subsequent IL-10 transgene expression...
  2. pmc Glia in pathological pain: a role for fractalkine
    E D Milligan
    Department of Neurosciences, University of New Mexico, Health Sciences Center, Albuquerque, NM 87131 0001 USA
    J Neuroimmunol 198:113-20. 2008
    ....
  3. pmc Pathological and protective roles of glia in chronic pain
    Erin D Milligan
    Department of Neurosciences, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131 0001, USA
    Nat Rev Neurosci 10:23-36. 2009
    ..Given the prevalence of chronic pain and the partial efficacy of current drugs, which exclusively target neuronal mechanisms, new strategies to manipulate neuron-glia interactions in pain processing hold considerable promise...
  4. ncbi request reprint Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats
    E D Milligan
    Department of Psychology and the Center for Neuroscience, University of Colorado at Boulder, Boulder, CO 80309 0345, USA
    Eur J Neurosci 20:2294-302. 2004
    ..Taken together, these initial investigations of spinal fractalkine effects suggest that exogenous and endogenous fractalkine are involved in spinal sensitization, including that induced by peripheral neuropathy...

Research Grants6

  1. Pain control via spinal interleukin-10 gene therapy
    ERIN MILLIGAN; Fiscal Year: 2007
    ..This approach to pain control represents a dramatic departure from all other available therapies. ..
  2. Spinal Neuroimmune Mechanisms Underlying IL-10 Gene Therapy for Pain Control
    Erin D Milligan; Fiscal Year: 2010
    ..Although, further improvement is needed for clinical trials, preliminary studies show an FDA-approved synthetic polymer improves pDNA-IL-10 drug delivery after a single injection at reduced dosage formulations. ..
  3. Pain control via spinal interleukin-10 gene therapy
    ERIN MILLIGAN; Fiscal Year: 2006
    ..This approach to pain control represents a dramatic departure from all other available therapies. ..
  4. Pain control via spinal interleukin-10 gene therapy
    ERIN MILLIGAN; Fiscal Year: 2004
    ..This approach to pain control represents a dramatic departure from all other available therapies. ..
  5. Pain control via spinal interleukin-10 gene therapy
    ERIN MILLIGAN; Fiscal Year: 2005
    ..This approach to pain control represents a dramatic departure from all other available therapies. ..